Temporal Macular Thinning Associated With X-Linked Alport Syndrome

Authors:

Abstract
Alport syndrome (AS) is a hereditary multisystem disease characterized by hematuria, progressive renal failure, hearing loss, anterior lenticonus, and retinopathy. The kidney, ear, lens, and retina all share similar collagen chains that are mutated in different forms of AS.1-7 Among patients with AS, 85% have the X-linked subtype (XLAS), with a prevalence of 1 in 5000 to 1 in 50 000 individuals.8 More than 400 mutations affecting the X-linked COL4A5 gene, which encodes for the α5 chain in type IV collagen, have been described.9 Contrary to common belief, female heterozygotes with a COL4A5 mutation are not asymptomatic carriers; they nearly always display microhematuria, and eventually as many as 40% of them will develop end-stage renal failure.10 The autosomal recessive form results from homozygous or compound heterozygous mutations of the COL4A3 or COL4A4 genes and makes up a much smaller percentage of individuals with AS, although the ocular findings are similar to the X-linked form.6,11 The rare autosomal dominant form occurs with a heterozygous mutation of the COL4A3 or COL4A4 gene and is associated with a low risk for ocular and auditory abnormalities but with a higher risk for renal failure in female patients than XLAS.12

This publication has 31 references indexed in Scilit: